clinicaltrialsarena2h
Ionis announces design for Phase III trial of Angelman syndrome therapy
Ionis has announced the design for a Phase III trial of ION582, a treatment for Angelman syndrome (AS), following discussions with the FDA.
clinicaltrialsarena15h
Lord O’Shaughnessy expresses optimism for clinical trials in the UK
The former health minister predicted a bright future for UK trials and outlined steps to ensure clinical research thrives.
clinicaltrialsarena19h
Penumbra reveals positive data for algorithm-assisted thrombectomy tech
Penumbra has developed a microprocessor with thrombus removal algorithms that, combined with audio-visual feedback, help ...
clinicaltrialsarena21h
Zymeworks doses first subject in Phase I trial of ZW191 for solid tumours
Zymeworks has dosed the first patient in its Phase I clinical trial of ZW191 aimed at treating advanced solid tumours.